NYSE:AMPE Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis $0.0022 0.00 (0.00%) (As of 09/13/2024 ET) Add Compare Share Share Today's Range$0.0022▼$0.002250-Day Range$0.00▼$0.1052-Week Range$0.00▼$7.47Volume26 shsAverage Volume77,230 shsMarket Capitalization$2,508.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends Get Ampio Pharmaceuticals alerts: Email Address Ad Market JARBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.Don't miss out. Get the full details on this AI bargain. About Ampio Pharmaceuticals Stock (NYSE:AMPE)Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.Read More AMPE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMPE Stock News HeadlinesSeptember 12, 2024 | americanbankingnews.comAmpio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.comMay 17, 2024 | finance.yahoo.comAmpio Pharmaceuticals, Inc. (AMPE)September 16, 2024 | Market JAR (Ad)BREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.April 3, 2024 | finance.yahoo.comAmpio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationApril 3, 2024 | prnewswire.comAmpio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationMarch 27, 2024 | investorplace.comAMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023March 26, 2024 | money.usnews.comAmpio Pharmaceuticals IncMarch 26, 2024 | finanznachrichten.deAmpio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC DeregistrationSeptember 16, 2024 | Market JAR (Ad)BREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.March 26, 2024 | msn.comUS Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence ReadingsMarch 25, 2024 | finance.yahoo.comAmpio Announces Voluntary Delisting and SEC DeregistrationFebruary 29, 2024 | msn.comAmpio Pharmaceuticals, Ironwood, Incannex among healthcare moversFebruary 15, 2024 | finanznachrichten.deAmpio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling StudiesFebruary 14, 2024 | prnewswire.comAmpio Provides Update on Results from Pre-IND Enabling StudiesJanuary 26, 2024 | msn.comAmpio Pharmaceuticals Announces At-The-Market Stock OfferingDecember 28, 2023 | seekingalpha.comSociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' packDecember 1, 2023 | msn.comWhat's Going On With Ampio Pharmaceuticals Stock?December 1, 2023 | msn.comRedhill Biopharma, Ampio Pharmaceuticals among healthcare moversSee More Headlines Receive AMPE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today9/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNYSE:AMPE CUSIPN/A CIK1411906 Webampiopharma.com Phone720-437-6500Fax720-437-6501Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($11.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,630,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-149.00% Return on Assets-103.79% Debt Debt-to-Equity RatioN/A Current Ratio2.41 Quick Ratio2.41 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.04 per share Price / Book0.00Miscellaneous Outstanding Shares1,140,000Free Float1,098,000Market Cap$2,508.00 OptionableNo Data Beta3.67 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Michael A. Martino (Age 67)CEO & Director Comp: $550kMr. Daniel G. Stokely CPA (Age 60)CFO, Corporate Secretary & Treasurer Comp: $338.31kDr. David Bar-Or M.D. (Age 75)Founder & Chairman of Scientific Advisory Board Comp: $145.6kApril RamirezClinical Trial ManagerKey CompetitorsGenocea BiosciencesNASDAQ:GNCAQGenocea BiosciencesNASDAQ:GNCAAridis PharmaceuticalsNASDAQ:ARDSStatera BiopharmaNASDAQ:STABScopus BioPharmaNASDAQ:SCPSView All Competitors AMPE Stock Analysis - Frequently Asked Questions How have AMPE shares performed this year? Ampio Pharmaceuticals' stock was trading at $2.05 at the beginning of 2024. Since then, AMPE shares have decreased by 99.9% and is now trading at $0.0022. View the best growth stocks for 2024 here. How were Ampio Pharmaceuticals' earnings last quarter? Ampio Pharmaceuticals, Inc. (NYSE:AMPE) announced its earnings results on Wednesday, November, 10th. The company reported ($0.40) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.40). When did Ampio Pharmaceuticals' stock split? Ampio Pharmaceuticals shares reverse split on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Ampio Pharmaceuticals? Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Ampio Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL). This page (NYSE:AMPE) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ampio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.